INSIDERFilingvia Quantisnow
Kewaunee Scientific Corporation logo

Kewaunee Scientific (KEQU) director Campbell received 690 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John Jette Campbell (director at Kewaunee Scientific Corporation, KEQU) reported that they received 690 shares on Sep 10, 2025. After these transactions the filing shows 690 shares held directly.

Reporting person
Campbell John Jette
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Sep 10, 2025Grant or award (A)Common Stock1+690--690 direct

Holdings before and after

  • Common Stock: 0 to 690 direct

Footnotes from the filing

  1. 1. Shares awarded under the Company's 2023 Omnibus Incentive Plan, representing the equity portion of the reporting person's annual director compensation.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Campbell report in this KEQU Form 4?

John Jette Campbell (director at Kewaunee Scientific Corporation, KEQU) reported that they received 690 shares on Sep 10, 2025. After these transactions the filing shows 690 shares held directly.

How many KEQU shares does Campbell hold after this filing?

The filing shows 690 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for KEQU

Earlier insider filings at KEQU

Quantisnow market dataNASDAQ
Kewaunee Scientific Corporation logo
KEQU
Kewaunee Scientific Corporation
Market cap
30-day
Sector
Industrials
Industry
Medical Specialities
Get push alerts for KEQU

Follow KEQU and get a push notification the moment its next story breaks.

Full KEQU profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KEQU (Kewaunee Scientific Corporation) and more on Quantisnow.